May. 1 at 2:28 PM
$CHUC British American Tobacco did not spend up to
$11.7 million buying into Charlie’s PMTA-linked assets because it believed flavored regulatory filings were meaningless. Now, with Charlie’s actively upgrading its remaining filings around FDA youth concerns and federal courts beginning to challenge the FDA’s flavored denial framework, investors have to ask a much bigger question. Did Big Tobacco already place its bet on Charlie’s PMTA optionality before Wall Street understood what was sitting there?
$MO $PM $TPB $ISPR
